Glycopyrrolate
Neurofibromatoses
Medical College of WisconsinSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Neurofibromatoses cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Bxcl501 Medical College of Wisconsin | Phase 4 | BB |
DINITROGEN MONOXIDE Medical College of Wisconsin | Phase 4 | BB |
PROPOFOL Medical College of Wisconsin | Phase 4 | BB |
LIDOCAINE Medical College of Wisconsin | Phase 4 | BB |
Sevoflurane Medical College of Wisconsin | Phase 4 | BB |
Rapamycin The University of Texas Health Science Center, Houston | Phase 1 | CC |
Same molecule, other indications
Glycopyrrolate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →